title: Atorvastatin pretreatment augments the effect of metformin in patients with polycystic ovary syndrome (PCOS).
authors.forename: Thozhukat
authors.initials: T
authors.lastname: Sathyapalan
authors.forename: Eric S
authors.initials: ES
authors.lastname: Kilpatrick
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Coady
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Atkin
mesh_terms: D000328:Adult; D000069059:Atorvastatin; D002097:C-Reactive Protein / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D007333:Insulin Resistance / Q000502:physiology; D008687:Metformin / Q000008:administration & dosage*; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy*; D011758:Pyrroles / Q000008:administration & dosage*; D013739:Testosterone / Q000097:blood
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D013739:Testosterone; D002097:C-Reactive Protein; D008687:Metformin; D000069059:Atorvastatin